Michael W Bonney insider trades

Open-market stock purchases and sales by Michael W Bonney, Director at Autolus Therapeutics plc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +19%.

Recent trades

DateStockTradeValue
Jun 29, 2026AUTL Autolus Therapeutics plcBought (not open market)—
Jun 29, 2026AUTL Autolus Therapeutics plcBought (not open market)—
Jun 29, 2026IMUX Immunic, IncBought (not open market)—

Companies traded

  • AUTL Autolus Therapeutics plc: other filings, last Jun 29, 2026
  • IMUX Immunic, Inc: other filings, last Jun 29, 2026
  • ALNY Alnylam Pharmaceuticals, Inc: 2 buys, 23 sales, last Aug 18, 2025
  • KLDO Kaleido Biosciences, Inc: 2 buys, last Jun 30, 2021
  • BMY Bristol Myers Squibb Co: 1 buy, last Jun 30, 2021
  • MGTA Magenta Therapeutics, Inc: other filings, last Jun 1, 2021
  • SRPT Sarepta Therapeutics, Inc: 1 buy, last Feb 28, 2020
  • CELG Celgene Corp /de/: 1 buy, last Nov 20, 2019
  • SYRS Syros Pharmaceuticals, Inc: other filings, last Jun 11, 2019
  • GBT Global Blood Therapeutics, Inc: other filings, last Jun 16, 2016
  • THW Tekla World HealthCare Fund: 1 buy, last Aug 17, 2015
  • NPSP NPS Pharmaceuticals Inc: 1 sale, last Feb 21, 2015

Get free alerts when Michael W Bonney files a new trade →